stars 1 stars 2 stars 3

LAGAP is a Swiss pharmaceutical company with a legacy of excellence since 1959. Today, we operate at the intersection of tradition and innovation, delivering high-quality branded generics to patients across Europe, the Middle East, Africa, and emerging markets. Our product portfolio focuses on essential, high-demand therapies that address pressing public health needs β€” combining proven safety, clinical efficacy, and broad accessibility. As we move into our next phase of growth, LAGAP is accelerating its efforts in international expansion and building strategic, long-term partnerships. Our commitment remains clear: to deliver trusted, affordable medicines that make a sustainable impact on global healthcare. We invite partners and clients who share our vision to join us in shaping the next chapter of LAGAP β€” where trusted medicines, global reach, and forward-thinking innovation come together to improve lives worldwide. Let’s shape the future of healthcare together. To explore partnership opportunities, connect with us at: πŸ“§ michael.zemp@lagap.ch 🌐 www.lagap.net

LAGAP SA Questions

The LAGAP SA annual revenue was $6.3 million in 2026.

Michael Zemp is the CFO and Board Member of LAGAP SA.

49 people are employed at LAGAP SA.

LAGAP SA is based in Bellinzona, Ticino.

The NAICS codes for LAGAP SA are [325, 32, 3254, 32541].

The SIC codes for LAGAP SA are [28, 283].

Top LAGAP SA Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users